212 related articles for article (PubMed ID: 19414262)
1. Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en.
Honda T; Kubo S; Masuda T; Arai M; Kobayashi Y; Yamashita M
Bioorg Med Chem Lett; 2009 Jun; 19(11):2938-40. PubMed ID: 19414262
[TBL] [Abstract][Full Text] [Related]
2. [Antiviral resistance of influenza viruses].
Saito R; Suzuki H
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():471-5. PubMed ID: 17455665
[No Abstract] [Full Text] [Related]
3. CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.
Yamashita M; Tomozawa T; Kakuta M; Tokumitsu A; Nasu H; Kubo S
Antimicrob Agents Chemother; 2009 Jan; 53(1):186-92. PubMed ID: 18955520
[TBL] [Abstract][Full Text] [Related]
4. Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza.
Yamashita M
Antivir Chem Chemother; 2010; 21(2):71-84. PubMed ID: 21107016
[TBL] [Abstract][Full Text] [Related]
5. Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
Liu KC; Lee PS; Wang SY; Cheng YS; Fang JM; Wong CH
Bioorg Med Chem; 2011 Aug; 19(16):4796-802. PubMed ID: 21778065
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).
Liu ZY; Wang B; Zhao LX; Li YH; Shao HY; Yi H; You XF; Li ZR
Bioorg Med Chem Lett; 2007 Sep; 17(17):4851-4. PubMed ID: 17611105
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Masuda T; Yoshida S; Arai M; Kaneko S; Yamashita M; Honda T
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1386-98. PubMed ID: 14646315
[TBL] [Abstract][Full Text] [Related]
8. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
9. Development of oseltamivir phosphonate congeners as anti-influenza agents.
Cheng TJ; Weinheimer S; Tarbet EB; Jan JT; Cheng YS; Shie JJ; Chen CL; Chen CA; Hsieh WC; Huang PW; Lin WH; Wang SY; Fang JM; Hu OY; Wong CH
J Med Chem; 2012 Oct; 55(20):8657-70. PubMed ID: 23009169
[TBL] [Abstract][Full Text] [Related]
10. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR
Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors.
Tolah AM; Azhar EI; Hashem AM
Saudi Med J; 2016 Apr; 37(4):461-5. PubMed ID: 27052292
[TBL] [Abstract][Full Text] [Related]
12. Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability.
Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Hoffmann A; Schmidtke M; Clement B
J Pharm Sci; 2015 Sep; 104(9):3208-19. PubMed ID: 26037932
[TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
Fu XZ; Jiang SH; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
[TBL] [Abstract][Full Text] [Related]
14. Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity.
Krecmerová M; Holý A; Pohl R; Masojídková M; Andrei G; Naesens L; Neyts J; Balzarini J; De Clercq E; Snoeck R
J Med Chem; 2007 Nov; 50(23):5765-72. PubMed ID: 17948980
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives.
Chand P; Babu YS; Bantia S; Rowland S; Dehghani A; Kotian PL; Hutchison TL; Ali S; Brouillette W; El-Kattan Y; Lin TH
J Med Chem; 2004 Apr; 47(8):1919-29. PubMed ID: 15055992
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.
Ye D; Shin WJ; Li N; Tang W; Feng E; Li J; He PL; Zuo JP; Kim H; Nam KY; Zhu W; Seong BL; No KT; Jiang H; Liu H
Eur J Med Chem; 2012 Aug; 54():764-70. PubMed ID: 22795831
[TBL] [Abstract][Full Text] [Related]
17. Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent.
Benzaria S; Pierra C; Bardiot D; Cretton-Scott E; Bridges EG; Zhou XJ; Standring D; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1003-6. PubMed ID: 14565331
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats.
Koyama K; Takahashi M; Nakai N; Takakusa H; Murai T; Hoshi M; Yamamura N; Kobayashi N; Okazaki O
Xenobiotica; 2010 Mar; 40(3):207-16. PubMed ID: 20146556
[TBL] [Abstract][Full Text] [Related]
19. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
[TBL] [Abstract][Full Text] [Related]
20. Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses.
Hsu PH; Chiu DC; Wu KL; Lee PS; Jan JT; Cheng YE; Tsai KC; Cheng TJ; Fang JM
Eur J Med Chem; 2018 Jun; 154():314-323. PubMed ID: 29843102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
